📰 Contract Development News
Page 87 - Contract Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Contract Development. Real-time updates on events, politics, business and more.
December 8, 2021
/PRNewswire/ -- SHIKIGAKU Co., Ltd. (TOKYO:7049) , the company that primarily provides management consulting and platform services based on "Shikigaku," an...
December 7, 2021
WAKEFIELD, MA / ACCESSWIRE / December 7, 2021 / Innovation Pharmaceuticals (OTCQB:IPIX) ("the Company"), a clinical stage biopharmaceutical company, today provides shareholders with perspectives on the
December 7, 2021
Best practices in collaboration with global customers in providing high-value Significant role in customer success Recognition for quality, innovation and loyalty as a strategic partner
December 7, 2021
Best practices in collaboration with global customers in providing high-value Significant role in customer success Recognition for quality, innovation and loyalty as a strategic partner for aseptic fill & finish solutions RAVENSBURG, GERMANY - Media OutReach - 7 December 2021 - Vetter , a leading global Contract Development and Manufacturing Organization (CDMO), has been awarded the Frost & Sullivan 's...
December 3, 2021
NJ Bio said it upped the size of its Princeton headquarters at 350 Carter Road from 35,000 square feet to approximately 79,000 square feet.
December 1, 2021
EQS Group-Ad-hoc: PolyPeptide Group / Key word: Personnel PolyPeptide Group appoints Neil Thompson as Director Global Sales and Marketing and member of the Executive Committee, succeeding Jan... | December 1, 2021
December 1, 2021
Investegate announcements from AGC Biologics, 4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab
December 1, 2021
PolyPeptide Group / Key word(s): Personnel01-Dec-2021 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Media Release - ad hoc announcement pursuant to Art. 53 LRPolyPeptide Group appoints Neil Thompson as Director Global Sal...
December 1, 2021
4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab AGC Biologics to produce Procizumab for early and late clinical phases at company’s Chiba and Copenhagen facilities GlobeNewswire December 01, 2021 Seattle, Dec. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new...
November 23, 2021
/PRNewswire/ -- Shoreline Biosciences, Inc. (Shoreline), a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized, and...